Inoue T - Search Results

1

Changes in bone mineral density at various sites in patients on hemodialysis due to chronic glomerulonephritis.

Miki T, Morita A, Nakatsuka K, Tabata T, Inoue T, Nishizawa Y, Morii H. Miki T, et al. Among authors: inoue t. Osteoporos Int. 1997;7 Suppl 3:S193-6. doi: 10.1007/BF03194371. Osteoporos Int. 1997. PMID: 9536331 No abstract available.

2

Plasma leptin level and its relationship with body composition in hemodialysis patients.

Nishizawa Y, Shoji T, Tanaka S, Yamashita M, Morita A, Emoto M, Tabata T, Inoue T, Morii H. Nishizawa Y, et al. Among authors: inoue t. Am J Kidney Dis. 1998 Apr;31(4):655-61. doi: 10.1053/ajkd.1998.v31.pm9531182. Am J Kidney Dis. 1998. PMID: 9531182

3

A case of membranous glomerulonephritis associated with gastric cancer.

Waki M, Ishimura E, Morii H, Sakai S, Saitoh S, Kobayashi T, Matsuyoshi M, Wada S, Tsukuda H, Emoto M, Shioi A, Nishizawa Y, Goto K, Sakurai M, Wakasa K, Yamashita Y, Inoue T, Chung YY, Sowa M. Waki M, et al. Among authors: inoue t. Osaka City Med J. 1997 Jun;43(1):95-105. Osaka City Med J. 1997. PMID: 9343999

4

QT interval prolongation in the patients receiving maintenance hemodialysis.

Suzuki R, Tsumura K, Inoue T, Kishimoto H, Morii H. Suzuki R, et al. Among authors: inoue t. Clin Nephrol. 1998 Apr;49(4):240-4. Clin Nephrol. 1998. PMID: 9582555

5

Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients.

Shoji T, Nishizawa Y, Kawagishi T, Kawasaki K, Taniwaki H, Tabata T, Inoue T, Morii H. Shoji T, et al. Among authors: inoue t. J Am Soc Nephrol. 1998 Jul;9(7):1277-84. doi: 10.1681/ASN.V971277. J Am Soc Nephrol. 1998. PMID: 9644639 Clinical Trial.

6

Effects of lipid-lowering drugs on intermediate-density lipoprotein in uremic patients.

Nishizawa Y, Shoji T, Tabata T, Inoue T, Morii H. Nishizawa Y, et al. Among authors: inoue t. Kidney Int Suppl. 1999 Jul;71:S134-6. doi: 10.1046/j.1523-1755.1999.07133.x. Kidney Int Suppl. 1999. PMID: 10412757 Free article.

7

Effect of an intermittent weekly dose of human parathyroid hormone (1-34) on osteoporosis: a randomized double-masked prospective study using three dose levels.

Fujita T, Inoue T, Morii H, Morita R, Norimatsu H, Orimo H, Takahashi HE, Yamamoto K, Fukunaga M. Fujita T, et al. Among authors: inoue t. Osteoporos Int. 1999;9(4):296-306. doi: 10.1007/s001980050151. Osteoporos Int. 1999. PMID: 10550446 Clinical Trial.

8

A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial.

Fukunaga M, Kushida K, Kishimoto H, Shiraki M, Taketani Y, Minaguchi H, Inoue T, Morita R, Morii H, Yamamoto K, Ohashi Y, Orimo H; Risedronate Phase III Research Group. Fukunaga M, et al. Among authors: inoue t. Osteoporos Int. 2002 Dec;13(12):971-9. doi: 10.1007/s001980200135. Osteoporos Int. 2002. PMID: 12459940 Clinical Trial.

9

Reappraisal of biochemical hepatitis C activity in hemodialysis patients.

Yuki N, Ishida H, Inoue T, Tabata T, Matsushita Y, Kishimoto H, Kato M, Masuzawa M, Sasaki Y, Hayashi N, Hori M. Yuki N, et al. Among authors: inoue t. J Clin Gastroenterol. 2000 Mar;30(2):187-94. doi: 10.1097/00004836-200003000-00012. J Clin Gastroenterol. 2000. PMID: 10730925

10

Rare somatic inactivation of the multiple endocrine neoplasia type 1 gene in secondary hyperparathyroidism of uremia.

Tahara H, Imanishi Y, Yamada T, Tsujimoto Y, Tabata T, Inoue T, Inaba M, Morii H, Nishizawa Y. Tahara H, et al. Among authors: inoue t. J Clin Endocrinol Metab. 2000 Nov;85(11):4113-7. doi: 10.1210/jcem.85.11.6950. J Clin Endocrinol Metab. 2000. PMID: 11095441

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,899 results

Search Page

Filters